A UC San Diego pilot study on parents of mass shooting victims finds that eight weeks of mindfulness training is effective in reducing trauma, depression, stress and grief caused by gun violence.
UC San Diego study shows neuroendocrine cells in the lungs drive a developmental lung disease, and a similar brain-lung interaction may contribute to COVID-19 symptoms. The findings suggest neuropeptides may be a promising therapeutic target for conditions with excess lung fluid.
People at risk of developing alcohol use disorder show lower functional connectivity between brain regions involved in processing facial expressions. Future psychoeducation programs focused on improving social and emotional processing may help prevent alcohol use disorder.
Researchers at UC San Diego used a multi-omics approach to investigate stool samples from patients with ulcerative colitis, a chronic inflammatory bowel disease. The team has identified the family of microbiome-derived enzymes driving the disease, and demonstrated a potential therapeutic solution.
A pioneering mentorship program at UC San Diego Health Sciences improved faculty satisfaction, especially among underrepresented faculty. The program serves as a successful model for other universities and medical schools looking to improve faculty diversity and success.
Computer simulations from UC San Diego School of Medicine reveal the action mechanism and substrate specificity of an important blood enzyme. These findings open the door for new therapeutics against cardiovascular disease, and further support a unifying theory of phospholipase function.
UC San Diego School of Medicine partners with The Michael J. Fox Foundation on a clinical study to identify biomarkers of Parkinson’s disease. The study seeks to recruit 4,000 participants by the end of 2023.
Neuroimaging study reveals potential brain mechanism underlying chronic neuropathic pain in individuals with HIV. Findings may guide new clinical treatments targeting patients’ expectations for pain relief.
Researchers at UC San Diego School of Medicine identify a strain of bacteria on healthy cats that produces antibiotics against severe skin infections. The findings may soon lead to new bacteriotherapies for humans and their pets, wherein cat bacteria is applied via topical cream or spray.
Researchers at UC San Diego School of Medicine awarded $11.7 million by National Institutes of Health to identify genomic and socioeconomic factors contributing to health and disease in admixed individuals. The new center aims to bring the genomic revolution to all.